CBD · Cannabidiol
A non-intoxicating cannabinoid found in hemp and the active ingredient in one FDA-approved prescription drug. That drug approval does not extend to other CBD products.
Educational library · Cannabinoids
Naturally occurring compounds found in hemp.
CBD, CBG, CBN and THC; the endocannabinoid system; minor cannabinoids; and the limits of current evidence.
Cannabinoids are a group of chemical compounds produced by Cannabis sativa. Researchers have identified more than 100, but only a small number have been studied extensively.
Interest in a cannabinoid, its presence in a product and evidence that a specific drug works are three different things. Product form, dose, route of administration, interactions and legal status all matter.
The endocannabinoid system
A signaling network that helps the body maintain balance.
The endocannabinoid system includes naturally produced signaling molecules, receptors and enzymes. It participates in processes including mood, memory, appetite, sleep, immune activity and pain signaling.
Plant cannabinoids can interact with this system in different ways. Those mechanisms are an active research area; a proposed mechanism is not proof that a consumer product prevents, treats or cures a condition.
Common cannabinoids
Similar names, different profiles.
The amounts and combinations found in a plant or product vary. Labels should identify what is present and provide the information consumers need to evaluate a serving.
CBG · Cannabigerol
A cannabinoid generally present in smaller amounts. Consumer interest is ahead of the clinical evidence needed for broad health conclusions.
CBN · Cannabinol
A cannabinoid that can form as THC changes over time. Its frequent appearance in products marketed for nighttime use is not, by itself, proof of a sleep benefit.
THC · Tetrahydrocannabinol
The principal intoxicating cannabinoid in cannabis at sufficient exposure. Hemp may contain THC within applicable legal limits, and full-spectrum products may contain trace amounts.
More and more cannabinoids
The long list is a research map, not a catalog of proven benefits.
CBDA, THCA, CBGA, CBC, THCV, CBDV, CBGV, CBCA, CBT and CBL are among the compounds discussed in scientific and product-development settings. Many remain lightly studied in people.
Responsible education keeps analytical identification, preclinical research, clinical evidence and authorized health claims separate.
Evidence & regulation
A hemp label does not establish safety, efficacy or approval.
FDA has approved certain prescription drugs that contain or relate to individual cannabinoids, but it has not approved the cannabis plant as a treatment. Over-the-counter cannabinoid products are not interchangeable with those prescription products.
FDA and NCCIH also identify possible adverse effects, drug interactions, contamination and label-accuracy concerns. Anyone considering cannabinoids for a health purpose should discuss that decision with a qualified health professional.
THE GOODNESS OF HEMP STORY
The GOOD Cannabinoid Story
A click-to-play introduction to cannabinoids and the questions responsible product education should answer.
EVIDENCE & CONTEXT
Health and legal context
This chapter is educational and is not medical advice, a therapeutic claim or a statement that any nonprescription cannabinoid product is FDA-approved. Laws and product status vary by formulation and jurisdiction.
SOURCES & FURTHER READING
Follow the evidence.
These links add current regulatory and evidence context to the original Goodness of Hemp educational material.
Keep exploring
Continue through hemp's connected supply chain.
Follow & share
Keep the Goodness moving.
Follow the campaign, share the educational chapters, or explore the proposed framework.